RUVBL1 and glioblastoma: In this study, we identified the Pontin chromatin remodelling factor as a key regulator of TβRII gene (TGFβR2) transcription, thus controlling TGFβ/SMAD signalling activity and TGFβ–dependent oncogenesis in GBM.